Showing results (171-180 of 283) with videos related to
Sort By:
Pageof 29
Journal of the Neurological Sciences|March 1, 1988
Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defectS Mossman, A Vincent, J Newsom-DavisLancet (London, England)|January 18, 1986
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entityS Mossman, A Vincent, J Newsom-DavisEuropean Journal of Pharmacology|July 27, 2001
The effect of adrenergic compounds on neurogenic dural vasodilatationS Akerman, D J Williamson, R G Hill, et al.Journal of Neuroscience Methods|December 24, 1997
A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperatureR J Storer, P Butler, K L Hoskin, et al.Pain|July 27, 2005
Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamusT Bartsch, M J Levy, Y E Knight, et al.The Journal of Headache and Pain|June 13, 2019
Trigeminal autonomic cephalalgias presenting in a multidisciplinary tertiary orofacial pain clinicD Y Wei, D Moreno-Ajona, T Renton, et al.Pain|May 26, 2004
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic areaT Bartsch, M J Levy, Y E Knight, et al.Brain Research|March 21, 1997
Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flowP J Goadsby, Y E Knight, K L Hoskin, et al.Neuropharmacology|May 30, 2001
4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist dosesR J Storer, S Akerman, H E Connor, et al.Neuroscience|August 9, 2005
Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the catK G Shields, R J Storer, S Akerman, et al.Pageof 29